EUVIMEDEUVIMED entdecken
Open Access

The Underappreciated Role of Secretory IgA in IBD

Giorgos Bamias iD, Konstantina Kitsou, Jesús Rivera-Nieves iD

Inflammatory Bowel Diseases · 01.08.2023 · 29 (8) · 1327-1341

DOI: 10.1093/ibd/izad024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 21.03.2023. Verfasst von Giorgos Bamias und 2 weiteren Autor:innen. Beteiligte Einrichtung: GI Unit, 3rd Academic Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, San Diego Digestive Diseases Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eighty percent of antibody secreting cells (ASCs) are found in the intestine, where they produce grams of immunoglobulin (Ig) A daily. immunoglobulin A is actively transcytosed into the lumen, where it plays a critical role in modulating the gut microbiota. Although loss of immune tolerance to bacterial antigens is the likely trigger of the dysregulated immune response that characterizes inflammatory bowel disease (IBD), little effort has been placed on understanding the interface between B cells, IgA, and the microbiota during initiation or progression of disease. This may be in part due to the misleading fact that IgA-deficient humans are mostly asymptomatic, likely due to redundant role of secretory (S) IgM. Intestinal B cell recruitment is critically dependent on integrin α4β7-MAdCAM-1 interactions, yet antibodies that target α4β7 (ie, vedolizumab), MAdCAM-1 (ie, ontamalimab), or both β7 integrins (α4β7 and αE [CD103] β7; etrolizumab) are in clinical use or development as IBD therapeutics. The effect of such interventions on the biology of IgA is largely unknown, yet a single dose of vedolizumab lowers SIgA levels in stool and weakens the oral immunization response to cholera vaccine in healthy volunteers. Thus, it is critical to further understand the role of these integrins for the migration of ASC and other cellular subsets during homeostasis and IBD-associated inflammation and the mode of action of drugs that interfere with this traffic. We have recently identified a subset of mature ASC that employs integrin αEβ7 to dock with intestinal epithelial cells, predominantly in the pericryptal region of the terminal ileum. This role for the integrin had not been appreciated previously, nor the αEβ7-dependent mechanism of IgA transcytosis that it supports. Furthermore, we find that B cells more than T cells are critically dependent on α4β7-MAdCAM-1 interactions; thus MAdCAM-1 blockade and integrin-β7 deficiency counterintuitively hasten colitis in interleukin-10-deficient mice. In both cases, de novo recruitment of IgA ASC to the intestinal lamina propria is compromised, leading to bacterial overgrowth, dysbiosis, and lethal colitis. Thus, despite the safe and effective use of anti-integrin antibodies in patients with IBD, much remains to be learned about their various cell targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitisHumansMiceAnimalsImmunoglobulin A, SecretoryIntegrinsIntestinesImmunoglobulin A

Stichwörter der Autor:innen

B cellsIBDIgAintegrinsplasma cells

Substanzen

Immunoglobulin A, SecretoryIntegrinsImmunoglobulin A

Autor:innen und Institutionen

  • GI Unit, 3rd Academic Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
  • Gastroenterology Section, San Diego VA Medical Center, La Jolla Village Drive, San Diego, CA, USA.
  • Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.

ORCID-Profile: Giorgos Bamias, Jesús Rivera-Nieves

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • San Diego Digestive Diseases Research Center
  • Chiba University-UC San Diego Program in Mucosal Immunology, Allergy and Vaccines

Zitieren

APA

Bamias, G., Kitsou, K., & Rivera-Nieves, J. (2023). The Underappreciated Role of Secretory IgA in IBD. Inflammatory Bowel Diseases, 29(8), 1327-1341. https://doi.org/10.1093/ibd/izad024

Vancouver

Bamias G, Kitsou K, Rivera-Nieves J. The Underappreciated Role of Secretory IgA in IBD. Inflammatory Bowel Diseases. 2023;29(8):1327-1341. doi:10.1093/ibd/izad024

BibTeX
@article{Bamias2023,
  author = {Bamias, Giorgos and Kitsou, Konstantina and Rivera-Nieves, Jesús},
  title = {The Underappreciated Role of Secretory IgA in IBD},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  volume = {29},
  number = {8},
  pages = {1327--1341},
  doi = {10.1093/ibd/izad024}
}
Kostenlos starten →